Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Public Health

Sec. Environmental Health and Exposome

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1642416

This article is part of the Research TopicInvisible Hazards, Lasting Impact: Airborne Toxicants and Systemic Disease from Environmental and Occupational ExposuresView all articles

The Burden of Carbon Monoxide Poisoning in China from 1990 to 2021 and Forecasts to 2050

Provisionally accepted
Yanwu  YuYanwu Yu1Jinzhou  YuJinzhou Yu2Ding  YuanDing Yuan1Fang  YangFang Yang1Hongyi  YanHongyi Yan1Pin  JiangPin Jiang1Mengnan  GuoMengnan Guo1Zhigao  XuZhigao Xu1Gaiqin  YanGaiqin Yan1Yan  ZhangYan Zhang1*Yanxia  GaoYanxia Gao1*
  • 1Emergency Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  • 2The University of Hong Kong, Hong Kong, Hong Kong, SAR China

The final, formatted version of the article will be published soon.

Aim: This study aimed to analyze the disease burden of carbon monoxide poisoning (COP) in China from 1990 to 2021 and to forecast future trends. Methods: Data were retrieved from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. The incidence, prevalence, mortality, and Disability Adjusted Life Years (DALYs) and their corresponding Age-Standardized Rates (ASRs) were examined to assess the burden of COP in China from 1990 to 2021. The Joinpoint regression model was used to investigate the trend changes of COP burden. The Age-Period-Cohort model was employed to delineate age, period, and cohort effects on the trends in disease burden. The Bayesian Age-Period-Cohort analysis method was applied to predict the changing trends of COP disease burden in China from 2022 to 2050. Results: In 2021, there were 152,820 incidences COP in China, with an Age-Standardized Incidence Rate (ASIR) of 13.06 per 100,000 population. There were 13,289 fatalities, corresponding to an Age-Standardized Mortality Rate (ASMR) of 0.8 per 100,000 population. The total DALYs amounted to 499,528, with an Age-Standardized DALY Rate (ASDR) of 35.02 per 100,000 population. The peak burden, as measured by DALYs, was observed in the 30-34 age group. Trend analysis employing Joinpoint regression revealed an initial increase in ASIR and Age-Standardized Prevalence Rate (ASPR) until 2015, followed by a subsequent decline. Moreover, the ASMR and ASDR showed fluctuant downward trends. Predictions from the Bayesian Age-Period-Cohort model suggest that the incidence, prevalence, mortality, and DALYs of COP in China are expected to increase from 2022 to 2050, peaking in 2038, while the ASRs are projected to decline. Conclusion: From 1990 to 2021, China experienced dynamic temporal patterns in the burden of COP, characterized by an initial rise in incidence and prevalence, followed by a decline in recent years, alongside a general downward trajectory in mortality and DALYs. Additionally, projections indicate a potential resurgence in COP-related burden in the coming decades.

Keywords: Carbon Monoxide Poisoning, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), Incidence, Prevalence, Mortality, Disability adjusted life years

Received: 09 Jun 2025; Accepted: 11 Aug 2025.

Copyright: © 2025 Yu, Yu, Yuan, Yang, Yan, Jiang, Guo, Xu, Yan, Zhang and Gao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yan Zhang, Emergency Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Yanxia Gao, Emergency Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.